nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—ABCB1—colon cancer	0.596	1	CbGaD
Loratadine—CYP2C9—Capecitabine—colon cancer	0.069	0.219	CbGbCtD
Loratadine—CYP2C8—Fluorouracil—colon cancer	0.0587	0.187	CbGbCtD
Loratadine—ABCB1—Irinotecan—colon cancer	0.0414	0.132	CbGbCtD
Loratadine—CYP2C9—Fluorouracil—colon cancer	0.0409	0.13	CbGbCtD
Loratadine—ABCB1—Vincristine—colon cancer	0.0362	0.115	CbGbCtD
Loratadine—CYP3A4—Irinotecan—colon cancer	0.0248	0.0788	CbGbCtD
Loratadine—ABCB1—Methotrexate—colon cancer	0.0219	0.0696	CbGbCtD
Loratadine—CYP3A4—Vincristine—colon cancer	0.0217	0.0689	CbGbCtD
Loratadine—Urine color abnormal—Capecitabine—colon cancer	0.00426	0.0484	CcSEcCtD
Loratadine—Chromaturia—Capecitabine—colon cancer	0.00281	0.0319	CcSEcCtD
Loratadine—Blister—Fluorouracil—colon cancer	0.00199	0.0226	CcSEcCtD
Loratadine—Drug interaction—Vincristine—colon cancer	0.00166	0.0188	CcSEcCtD
Loratadine—Salivary hypersecretion—Irinotecan—colon cancer	0.00146	0.0165	CcSEcCtD
Loratadine—Blister—Capecitabine—colon cancer	0.00139	0.0158	CcSEcCtD
Loratadine—Desloratadine—ABCB1—colon cancer	0.0012	1	CrCbGaD
Loratadine—Dermatitis bullous—Fluorouracil—colon cancer	0.00109	0.0124	CcSEcCtD
Loratadine—Lethargy—Fluorouracil—colon cancer	0.00107	0.0121	CcSEcCtD
Loratadine—Depression—Vincristine—colon cancer	0.00086	0.00975	CcSEcCtD
Loratadine—Increased appetite—Capecitabine—colon cancer	0.000776	0.0088	CcSEcCtD
Loratadine—Dermatitis bullous—Capecitabine—colon cancer	0.000763	0.00866	CcSEcCtD
Loratadine—Epistaxis—Fluorouracil—colon cancer	0.000759	0.0086	CcSEcCtD
Loratadine—Lethargy—Capecitabine—colon cancer	0.000744	0.00844	CcSEcCtD
Loratadine—Pharyngitis—Fluorouracil—colon cancer	0.000717	0.00813	CcSEcCtD
Loratadine—Alopecia—Vincristine—colon cancer	0.000684	0.00776	CcSEcCtD
Loratadine—Immune system disorder—Irinotecan—colon cancer	0.000681	0.00772	CcSEcCtD
Loratadine—Arrhythmia—Irinotecan—colon cancer	0.000673	0.00764	CcSEcCtD
Loratadine—Alopecia—Irinotecan—colon cancer	0.000666	0.00756	CcSEcCtD
Loratadine—Abdominal pain upper—Capecitabine—colon cancer	0.000666	0.00756	CcSEcCtD
Loratadine—Gastritis—Capecitabine—colon cancer	0.000645	0.00732	CcSEcCtD
Loratadine—Arrhythmia—Fluorouracil—colon cancer	0.000645	0.00732	CcSEcCtD
Loratadine—Alopecia—Fluorouracil—colon cancer	0.000638	0.00724	CcSEcCtD
Loratadine—Agitation—Vincristine—colon cancer	0.000619	0.00702	CcSEcCtD
Loratadine—Ill-defined disorder—Irinotecan—colon cancer	0.000609	0.00691	CcSEcCtD
Loratadine—Malaise—Irinotecan—colon cancer	0.000592	0.00671	CcSEcCtD
Loratadine—Syncope—Irinotecan—colon cancer	0.000589	0.00667	CcSEcCtD
Loratadine—Hypertension—Vincristine—colon cancer	0.000582	0.0066	CcSEcCtD
Loratadine—Loss of consciousness—Irinotecan—colon cancer	0.000577	0.00654	CcSEcCtD
Loratadine—Myalgia—Vincristine—colon cancer	0.000574	0.00651	CcSEcCtD
Loratadine—Cough—Irinotecan—colon cancer	0.000573	0.0065	CcSEcCtD
Loratadine—Hypertension—Irinotecan—colon cancer	0.000567	0.00643	CcSEcCtD
Loratadine—Depression—Capecitabine—colon cancer	0.00056	0.00636	CcSEcCtD
Loratadine—Lethargy—Methotrexate—colon cancer	0.000554	0.00628	CcSEcCtD
Loratadine—Discomfort—Irinotecan—colon cancer	0.000552	0.00626	CcSEcCtD
Loratadine—Anaphylactic shock—Vincristine—colon cancer	0.00055	0.00624	CcSEcCtD
Loratadine—Nervous system disorder—Vincristine—colon cancer	0.000539	0.00612	CcSEcCtD
Loratadine—Anaphylactic shock—Irinotecan—colon cancer	0.000536	0.00607	CcSEcCtD
Loratadine—Chest pain—Fluorouracil—colon cancer	0.000535	0.00607	CcSEcCtD
Loratadine—Myalgia—Fluorouracil—colon cancer	0.000535	0.00607	CcSEcCtD
Loratadine—Hepatobiliary disease—Capecitabine—colon cancer	0.000532	0.00603	CcSEcCtD
Loratadine—Epistaxis—Capecitabine—colon cancer	0.00053	0.00601	CcSEcCtD
Loratadine—Discomfort—Fluorouracil—colon cancer	0.000529	0.006	CcSEcCtD
Loratadine—Shock—Irinotecan—colon cancer	0.000527	0.00598	CcSEcCtD
Loratadine—Nervous system disorder—Irinotecan—colon cancer	0.000525	0.00596	CcSEcCtD
Loratadine—Hypotension—Vincristine—colon cancer	0.000514	0.00583	CcSEcCtD
Loratadine—Anaphylactic shock—Fluorouracil—colon cancer	0.000513	0.00582	CcSEcCtD
Loratadine—Nervous system disorder—Fluorouracil—colon cancer	0.000503	0.00571	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Vincristine—colon cancer	0.000501	0.00568	CcSEcCtD
Loratadine—Pharyngitis—Capecitabine—colon cancer	0.000501	0.00568	CcSEcCtD
Loratadine—Tachycardia—Fluorouracil—colon cancer	0.000501	0.00568	CcSEcCtD
Loratadine—Hypotension—Irinotecan—colon cancer	0.0005	0.00568	CcSEcCtD
Loratadine—Insomnia—Vincristine—colon cancer	0.000497	0.00564	CcSEcCtD
Loratadine—Paraesthesia—Vincristine—colon cancer	0.000494	0.0056	CcSEcCtD
Loratadine—Insomnia—Irinotecan—colon cancer	0.000484	0.00549	CcSEcCtD
Loratadine—Paraesthesia—Irinotecan—colon cancer	0.000481	0.00545	CcSEcCtD
Loratadine—Hypotension—Fluorouracil—colon cancer	0.000479	0.00544	CcSEcCtD
Loratadine—Somnolence—Irinotecan—colon cancer	0.000476	0.0054	CcSEcCtD
Loratadine—Gastrointestinal disorder—Vincristine—colon cancer	0.000475	0.00539	CcSEcCtD
Loratadine—Fatigue—Vincristine—colon cancer	0.000474	0.00538	CcSEcCtD
Loratadine—Dyspepsia—Irinotecan—colon cancer	0.000471	0.00535	CcSEcCtD
Loratadine—Tinnitus—Capecitabine—colon cancer	0.00047	0.00534	CcSEcCtD
Loratadine—Constipation—Vincristine—colon cancer	0.00047	0.00533	CcSEcCtD
Loratadine—Pain—Vincristine—colon cancer	0.00047	0.00533	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000467	0.0053	CcSEcCtD
Loratadine—Insomnia—Fluorouracil—colon cancer	0.000464	0.00526	CcSEcCtD
Loratadine—Gastrointestinal disorder—Irinotecan—colon cancer	0.000462	0.00524	CcSEcCtD
Loratadine—Fatigue—Irinotecan—colon cancer	0.000462	0.00524	CcSEcCtD
Loratadine—Paraesthesia—Fluorouracil—colon cancer	0.000461	0.00522	CcSEcCtD
Loratadine—Constipation—Irinotecan—colon cancer	0.000458	0.00519	CcSEcCtD
Loratadine—Pain—Irinotecan—colon cancer	0.000458	0.00519	CcSEcCtD
Loratadine—Somnolence—Fluorouracil—colon cancer	0.000456	0.00517	CcSEcCtD
Loratadine—Immune system disorder—Capecitabine—colon cancer	0.000456	0.00517	CcSEcCtD
Loratadine—Dyspepsia—Fluorouracil—colon cancer	0.000452	0.00512	CcSEcCtD
Loratadine—Arrhythmia—Capecitabine—colon cancer	0.000451	0.00511	CcSEcCtD
Loratadine—Gastrointestinal pain—Vincristine—colon cancer	0.00045	0.0051	CcSEcCtD
Loratadine—Alopecia—Capecitabine—colon cancer	0.000446	0.00506	CcSEcCtD
Loratadine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000443	0.00502	CcSEcCtD
Loratadine—Feeling abnormal—Irinotecan—colon cancer	0.000441	0.00501	CcSEcCtD
Loratadine—Pain—Fluorouracil—colon cancer	0.000439	0.00498	CcSEcCtD
Loratadine—Gastrointestinal pain—Irinotecan—colon cancer	0.000438	0.00497	CcSEcCtD
Loratadine—Abdominal pain—Vincristine—colon cancer	0.000435	0.00493	CcSEcCtD
Loratadine—Body temperature increased—Vincristine—colon cancer	0.000435	0.00493	CcSEcCtD
Loratadine—Dysgeusia—Capecitabine—colon cancer	0.00043	0.00488	CcSEcCtD
Loratadine—Abdominal pain—Irinotecan—colon cancer	0.000423	0.0048	CcSEcCtD
Loratadine—Body temperature increased—Irinotecan—colon cancer	0.000423	0.0048	CcSEcCtD
Loratadine—Feeling abnormal—Fluorouracil—colon cancer	0.000423	0.00479	CcSEcCtD
Loratadine—Drowsiness—Methotrexate—colon cancer	0.000418	0.00475	CcSEcCtD
Loratadine—Depression—Methotrexate—colon cancer	0.000417	0.00473	CcSEcCtD
Loratadine—Ill-defined disorder—Capecitabine—colon cancer	0.000408	0.00462	CcSEcCtD
Loratadine—Body temperature increased—Fluorouracil—colon cancer	0.000406	0.0046	CcSEcCtD
Loratadine—Malaise—Capecitabine—colon cancer	0.000396	0.00449	CcSEcCtD
Loratadine—Hepatobiliary disease—Methotrexate—colon cancer	0.000396	0.00449	CcSEcCtD
Loratadine—Epistaxis—Methotrexate—colon cancer	0.000395	0.00448	CcSEcCtD
Loratadine—Asthenia—Vincristine—colon cancer	0.000395	0.00448	CcSEcCtD
Loratadine—Syncope—Capecitabine—colon cancer	0.000394	0.00447	CcSEcCtD
Loratadine—Palpitations—Capecitabine—colon cancer	0.000388	0.0044	CcSEcCtD
Loratadine—Loss of consciousness—Capecitabine—colon cancer	0.000386	0.00438	CcSEcCtD
Loratadine—Asthenia—Irinotecan—colon cancer	0.000384	0.00436	CcSEcCtD
Loratadine—Cough—Capecitabine—colon cancer	0.000383	0.00435	CcSEcCtD
Loratadine—Hypertension—Capecitabine—colon cancer	0.000379	0.0043	CcSEcCtD
Loratadine—Diarrhoea—Vincristine—colon cancer	0.000376	0.00427	CcSEcCtD
Loratadine—Chest pain—Capecitabine—colon cancer	0.000374	0.00424	CcSEcCtD
Loratadine—Myalgia—Capecitabine—colon cancer	0.000374	0.00424	CcSEcCtD
Loratadine—Pharyngitis—Methotrexate—colon cancer	0.000373	0.00423	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000371	0.00421	CcSEcCtD
Loratadine—Discomfort—Capecitabine—colon cancer	0.000369	0.00419	CcSEcCtD
Loratadine—Diarrhoea—Irinotecan—colon cancer	0.000366	0.00416	CcSEcCtD
Loratadine—Dry mouth—Capecitabine—colon cancer	0.000366	0.00415	CcSEcCtD
Loratadine—Dizziness—Vincristine—colon cancer	0.000364	0.00412	CcSEcCtD
Loratadine—Dizziness—Irinotecan—colon cancer	0.000354	0.00402	CcSEcCtD
Loratadine—Shock—Capecitabine—colon cancer	0.000353	0.004	CcSEcCtD
Loratadine—Nervous system disorder—Capecitabine—colon cancer	0.000352	0.00399	CcSEcCtD
Loratadine—Diarrhoea—Fluorouracil—colon cancer	0.000351	0.00398	CcSEcCtD
Loratadine—Tinnitus—Methotrexate—colon cancer	0.00035	0.00397	CcSEcCtD
Loratadine—Tachycardia—Capecitabine—colon cancer	0.00035	0.00397	CcSEcCtD
Loratadine—Vomiting—Vincristine—colon cancer	0.00035	0.00397	CcSEcCtD
Loratadine—Skin disorder—Capecitabine—colon cancer	0.000348	0.00395	CcSEcCtD
Loratadine—Rash—Vincristine—colon cancer	0.000347	0.00393	CcSEcCtD
Loratadine—Dermatitis—Vincristine—colon cancer	0.000346	0.00393	CcSEcCtD
Loratadine—Headache—Vincristine—colon cancer	0.000345	0.00391	CcSEcCtD
Loratadine—Vomiting—Irinotecan—colon cancer	0.000341	0.00386	CcSEcCtD
Loratadine—Immune system disorder—Methotrexate—colon cancer	0.000339	0.00385	CcSEcCtD
Loratadine—Dizziness—Fluorouracil—colon cancer	0.000339	0.00385	CcSEcCtD
Loratadine—Rash—Irinotecan—colon cancer	0.000338	0.00383	CcSEcCtD
Loratadine—Dermatitis—Irinotecan—colon cancer	0.000337	0.00383	CcSEcCtD
Loratadine—Headache—Irinotecan—colon cancer	0.000336	0.00381	CcSEcCtD
Loratadine—Hypotension—Capecitabine—colon cancer	0.000335	0.0038	CcSEcCtD
Loratadine—Alopecia—Methotrexate—colon cancer	0.000332	0.00376	CcSEcCtD
Loratadine—Nausea—Vincristine—colon cancer	0.000327	0.00371	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000327	0.0037	CcSEcCtD
Loratadine—Vomiting—Fluorouracil—colon cancer	0.000326	0.0037	CcSEcCtD
Loratadine—Insomnia—Capecitabine—colon cancer	0.000324	0.00368	CcSEcCtD
Loratadine—Rash—Fluorouracil—colon cancer	0.000323	0.00367	CcSEcCtD
Loratadine—Dermatitis—Fluorouracil—colon cancer	0.000323	0.00366	CcSEcCtD
Loratadine—Paraesthesia—Capecitabine—colon cancer	0.000322	0.00365	CcSEcCtD
Loratadine—Headache—Fluorouracil—colon cancer	0.000321	0.00364	CcSEcCtD
Loratadine—Dysgeusia—Methotrexate—colon cancer	0.00032	0.00363	CcSEcCtD
Loratadine—Nausea—Irinotecan—colon cancer	0.000318	0.00361	CcSEcCtD
Loratadine—Dyspepsia—Capecitabine—colon cancer	0.000316	0.00358	CcSEcCtD
Loratadine—Gastrointestinal disorder—Capecitabine—colon cancer	0.000309	0.00351	CcSEcCtD
Loratadine—Fatigue—Capecitabine—colon cancer	0.000309	0.00351	CcSEcCtD
Loratadine—Pain—Capecitabine—colon cancer	0.000307	0.00348	CcSEcCtD
Loratadine—Constipation—Capecitabine—colon cancer	0.000307	0.00348	CcSEcCtD
Loratadine—Nausea—Fluorouracil—colon cancer	0.000305	0.00346	CcSEcCtD
Loratadine—Ill-defined disorder—Methotrexate—colon cancer	0.000303	0.00344	CcSEcCtD
Loratadine—Feeling abnormal—Capecitabine—colon cancer	0.000295	0.00335	CcSEcCtD
Loratadine—Malaise—Methotrexate—colon cancer	0.000295	0.00334	CcSEcCtD
Loratadine—Gastrointestinal pain—Capecitabine—colon cancer	0.000293	0.00332	CcSEcCtD
Loratadine—Cough—Methotrexate—colon cancer	0.000285	0.00324	CcSEcCtD
Loratadine—Body temperature increased—Capecitabine—colon cancer	0.000283	0.00321	CcSEcCtD
Loratadine—Abdominal pain—Capecitabine—colon cancer	0.000283	0.00321	CcSEcCtD
Loratadine—Chest pain—Methotrexate—colon cancer	0.000278	0.00316	CcSEcCtD
Loratadine—Myalgia—Methotrexate—colon cancer	0.000278	0.00316	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000276	0.00314	CcSEcCtD
Loratadine—Discomfort—Methotrexate—colon cancer	0.000275	0.00312	CcSEcCtD
Loratadine—Anaphylactic shock—Methotrexate—colon cancer	0.000267	0.00303	CcSEcCtD
Loratadine—Nervous system disorder—Methotrexate—colon cancer	0.000262	0.00297	CcSEcCtD
Loratadine—Skin disorder—Methotrexate—colon cancer	0.000259	0.00294	CcSEcCtD
Loratadine—Asthenia—Capecitabine—colon cancer	0.000257	0.00292	CcSEcCtD
Loratadine—Hypotension—Methotrexate—colon cancer	0.000249	0.00283	CcSEcCtD
Loratadine—Diarrhoea—Capecitabine—colon cancer	0.000245	0.00278	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000243	0.00276	CcSEcCtD
Loratadine—Insomnia—Methotrexate—colon cancer	0.000241	0.00274	CcSEcCtD
Loratadine—Paraesthesia—Methotrexate—colon cancer	0.00024	0.00272	CcSEcCtD
Loratadine—Somnolence—Methotrexate—colon cancer	0.000237	0.00269	CcSEcCtD
Loratadine—Dizziness—Capecitabine—colon cancer	0.000237	0.00269	CcSEcCtD
Loratadine—Dyspepsia—Methotrexate—colon cancer	0.000235	0.00266	CcSEcCtD
Loratadine—Gastrointestinal disorder—Methotrexate—colon cancer	0.00023	0.00261	CcSEcCtD
Loratadine—Fatigue—Methotrexate—colon cancer	0.00023	0.00261	CcSEcCtD
Loratadine—Pain—Methotrexate—colon cancer	0.000228	0.00259	CcSEcCtD
Loratadine—Vomiting—Capecitabine—colon cancer	0.000228	0.00258	CcSEcCtD
Loratadine—Rash—Capecitabine—colon cancer	0.000226	0.00256	CcSEcCtD
Loratadine—Dermatitis—Capecitabine—colon cancer	0.000226	0.00256	CcSEcCtD
Loratadine—Headache—Capecitabine—colon cancer	0.000225	0.00255	CcSEcCtD
Loratadine—Feeling abnormal—Methotrexate—colon cancer	0.00022	0.00249	CcSEcCtD
Loratadine—Gastrointestinal pain—Methotrexate—colon cancer	0.000218	0.00247	CcSEcCtD
Loratadine—Nausea—Capecitabine—colon cancer	0.000213	0.00241	CcSEcCtD
Loratadine—Body temperature increased—Methotrexate—colon cancer	0.000211	0.00239	CcSEcCtD
Loratadine—Abdominal pain—Methotrexate—colon cancer	0.000211	0.00239	CcSEcCtD
Loratadine—Asthenia—Methotrexate—colon cancer	0.000191	0.00217	CcSEcCtD
Loratadine—Diarrhoea—Methotrexate—colon cancer	0.000183	0.00207	CcSEcCtD
Loratadine—Dizziness—Methotrexate—colon cancer	0.000176	0.002	CcSEcCtD
Loratadine—Vomiting—Methotrexate—colon cancer	0.00017	0.00192	CcSEcCtD
Loratadine—Rash—Methotrexate—colon cancer	0.000168	0.00191	CcSEcCtD
Loratadine—Dermatitis—Methotrexate—colon cancer	0.000168	0.00191	CcSEcCtD
Loratadine—Headache—Methotrexate—colon cancer	0.000167	0.0019	CcSEcCtD
Loratadine—Nausea—Methotrexate—colon cancer	0.000159	0.0018	CcSEcCtD
